{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:57:54Z","timestamp":1760785074426,"version":"3.41.2"},"reference-count":3,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2022.840074","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:32:45Z","timestamp":1656937965000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Lessons Learned from Translational Research in Neuromuscular Diseases: Impact on Study Design, Outcome Measures and Managing Expectation"],"prefix":"10.3389","volume":"13","author":[{"given":"Anna G.","family":"Mayhew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ana.26044","article-title":"Assessing Dysferlinopathy Patients over Three Years with a New Motor Scale","volume":"89","author":"Jacobs","year":"2021","journal-title":"Ann. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3389\/FPHAR.2021.735912\/BIBTEX","article-title":"Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy","volume":"12","author":"Markati","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13023-017-0718-x","article-title":"Measuring what Matters to Rare Disease Patients - Reflections on the Work by the IRDiRC Taskforce on Patient-Centered Outcome Measures","volume":"12","author":"Morel","year":"2017","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.840074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T12:32:47Z","timestamp":1656937967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.840074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":3,"alternative-id":["10.3389\/fgene.2022.840074"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.840074","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"article-number":"840074"}}